Mangoceuticals Inc. has announced new compensation agreements for its key executives and board members effective September 9, 2025. Chief Executive Officer Jacob D. Cohen received a bonus of 500,000 shares of common stock and options to purchase 2,000,000 shares, with the options vesting over 18 months. Chief Financial Officer Eugene M. Johnston was awarded 100,000 shares for his services during the year. Non-executive board members Kenny Myers, Alex Hamilton, and Lorraine D'Alessio each received 100,000 shares. The stock options for Mr. Cohen are set at an exercise price of $2.30 per share and vest fully upon specific conditions, including termination without cause or a change in control of the company.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mangoceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-25-013213), on September 12, 2025, and is solely responsible for the information contained therein.